INTRODUCTION
are each effective with only a limited subset of HIV-1 Lentiviruses such as human immunodeficiency virus isolates. Rocancourt et al. (1990) and, more recently, (HIV) and simian immunodeficiency virus (SIV) are charKimpton and Emerman (1992) developed a rapid method acterized by a high degree of genotypic and phenotypic of detecting HIV-1 based on the viral activation of an diversity (reviewed in Cheng-Mayer, 1990; Fenyö et al., integrated LTR-b-galactosidase (LTR-b-gal) gene in 1989; Zack and Overbaugh, 1994) . For example, in human CD4 / HeLa cells. This assay exploits the ability of the T-cell lines, primate lentiviruses display distinct differ-HIV Tat protein to transactivate the b-gal gene driven by ences in host cell specificity, replication rate, and cell the HIV-1 long terminal repeat (LTR) promoter. The nuclei killing. Standard methods for quantitatively measuring of infected cells stain blue after incubation with X-gal, infectious HIV and SIV typically require infection and and individual infected cells are counted in situ with the spread of the virus in T-cell lines, and replication differaid of a light microscope. Unfortunately, this assay also ences can make the comparison of phenotypically dishas limitations; the HeLa-CD4-LTR-b-gal cell line develtinct strains problematic. Similarly, protocols that meaoped by Kimpton and Emerman [called the multinuclear sure infectious virus by cytopathic effect or syncytia, for activation of a galactosidase indicator (MAGI) cell line] is example, neutralization assays, will be biased against not sensitive to infection by most primary HIV-1 isolates viral isolates that are noncytopathic or nonsyncytia induc- (Kimpton and Emerman, 1992) . In addition, one report ing. Other than the viral receptor, the cellular factors that indicates that HeLa-CD4 cells are moderately susceptidetermine viral tropism and syncytia-inducing ability are ble to SIVagm and, to a lesser extent, SIVmac infection largely uncharacterized.
( Rocancourt et al., 1990 ), but we have found that the Human cell lines engineered to express human CD4 HeLa-CD4 (MAGI) cell line is not susceptible to SIVMcan be infected by HIV type 1 (HIV-1) to varying degrees neCL8 infection (Chackerian and Overbaugh, unpub-(Cheng-Mayer, 1990; Clapham et al., 1991) . Similarly, lished observations). assays that require only a single round of infection to Recently, Goldstein et al. (1995) reported that a rhesus detect infectious HIV-1 in CD4 cell lines (Chesebro and macaque cell line expressing human CD4 (CMMT-CD4) is sensitive to SIVsm, SIVmac, and SIVagm infection (Goldstein et al., 1995) . In addition, previous studies had the HIV-1 LTR (Viglianti and Mullins, 1988) . On the basis high CD4 expression one additional time (as described above). of these observations, we engineered the CMMT cell line to carry the human CD4 gene and an HIV-1-LTR-b-gal Viruses and infections reporter gene. This cell line, the simian MAGI (sMAGI) line, is highly sensitive to infection by T-cell-and macrophage-SIV stocks were prepared by infecting CEM 1 174 tropic SIV strains, as well as primary and laboratorycells, C8166 cells, or Macaca nemestrina peripheral adapted isolates. Using these indicator cells the titer of blood mononuclear cells (PBMCs) with cell-free virus and neutralizing antibody activity in macaque plasma against culturing for 2 to 4 weeks. Cells were cultured in RPMI three commonly used SIV isolates was determined. Our 1640 supplemented with 10% fetal calf serum, 100 U per analysis showed that this approach can be used to define milliliter penicillin, 100 mg per milliliter streptomycin, 1 neutralizing antibody titers to homologous and heterolomM sodium pyruvate, and 100 mM nonessential amino gous virus isolates. We also tested the sensitivity of the acids; 1% phytohemagglutinin-M and 50 U per milliliter sMAGI cell line to isolates of HIV-1 and HIV-2. The cell interleukin-2 were added to PBMCs in culture. Cell-free line was not susceptible to infection by either cloned or virus was harvested from the cultures by low-speed cenprimary isolates of HIV-1. But, the sMAGI cells were sensitrifugation for 5 min to remove the majority of cells foltive to infection by some strains of HIV-2.
lowed by filtration through a 0.22 mM filter. Viral stocks harvested from CEM 1 174 cells include the following: SIVMneCL8 (Morton et al., 1989; Overbaugh et al., 1991) , MATERIALS AND METHODS a cloned cytopathic and syncytia-inducing variant of SIV-
Cell lines
MneCL8, SIVMne170 (Kimata and Overbaugh, unpublished observations), a chimeric virus M87004 35wk, CMMT cells (a rhesus macaque mammary tumor cell which was constructed by inserting the majority of gp120 line) were obtained from the American Type Culture Colfrom clone 35wk:1-1 (Overbaugh et al., 1991) into an SIVlection (Rockville, MD). Cells were grown in Dulbecco's MneCL8 background (Rudensey and Overbaugh, unpubmodified Eagle's medium (DMEM) supplemented with lished observations), SIVmac239 (Kestler et al., 1990) , 10% fetal calf serum, 100 U per milliliter penicillin, 100
and an uncloned virus pool, SIVsmE660 (Hirsch and mg per milliliter streptomycin, and 300 mg per milliliter Johnson, 1994) . SIVmac1A11 (Marthas et al., 1989 (Marthas et al., , 1990 ) glutamine (complete DMEM). CMMT-CD4 cells were and uncloned SIVMne (Benveniste et al., 1986) were constructed by infecting CMMT cells with the amphogrown in macaque PBMCs. Primary isolates derived from tropic retroviral vector PA317/LT4SN (Kimpton and Emerthe PBMCs of an infected M. nemestrina (M87004) 170 man, 1992; McElrath et al., 1994) . Cells were selected weeks postinoculation and passaged through CEM 1 by growth in complete DMEM plus 0.2 mg per milliliter 174 cells, C8166 cells, or macaque PBMCs were degentamycin (G418, at an active concentration of 700 mg scribed previously (Rudensey et al., 1993) . per milligram; GIBCO, Grand Island, NY) . From the G418-Cell free HIV-2 EHO, HIV-2 KR, and HIV-2 ROD stocks resistant cell population, we used fluorescence-activated were grown in U937 cells, CEM 1 174 cells, and human cell sorting (FACS) to segregate the top 15-30% of cells PBMCs, respectively. HIV-1 LAI was grown in CEM 1 that expressed the highest surface levels of CD4, as was 174 cells and human PBMCs. HIV-1 BAL was grown in done with the original MAGI cells (Kimpton and Emerhuman PBMCs. WH91-330 was passaged through human, 1992). To further purify this high CD4-expressing man PBMCs (White-Scharf et al., 1993) . Primary isolates subpopulation, the cells were resorted for high CD4 ex-MM1-2201 and BB2-2847 from a Kenyan woman and pression by FACS after culturing for an additional 2 and infant, respectively, were obtained by coculturing their 4 weeks under G418 selection.
PBMCs with donor human PBMCs for 4 weeks (Welch, CMMT-CD4-LTR-b-gal indicator cells were conKreiss, and Overbaugh, unpublished observations). The structed by transfecting CMMT-CD4 cells with plasmid following reagents were obtained through the AIDS RepEQ447 (Harrington and Geballe, 1993) using Lipofectin search and Reference Reagent Program, Division of (GIBCO BRL, Gaithersburg, MD). pEQ447 contains the AIDS, NIAID, NIH: p239SpE3 and p239SpSp5 from Dr. hygromycin resistance gene under the control of the cytoRonald Desrosiers (Kestler et al., 1990) , HIV-2 CBL-20/ megalovirus major immediate-early promoter, the b-gal H9 from Dr. Robin Weiss (Schulz et al., 1990) , and HIVgene downstream of a truncated HIV-1 LTR, and the sim-2 D194/HUT-78 from Dr. Hagen von Briesen (Kuhnel et ian virus 40 T antigen nuclear localization signal. Cells al., 1989; von Briesen et al., 1990) . were grown in complete DMEM plus 0.2 mg per milliliter of G418 (at an active concentration of 700 mg per milliVirus assays gram) and 50 U per milliliter hygromycin (Calbiochem, La Jolla, CA) in order to isolate single cell clones. Thirty
The CMMT-CD4-LTR-b-gal indicator cells were plated in 12-well plates at 4 1 10 4 cells per well in complete of the G418 and hygromycin-resistant colonies were expanded in culture, and subsequently the two clonal cell DMEM the day before infection. The cells were infected by removing the media from each well and adding dilutions of lines that we chose for further study were sorted for virus in a total volume of 300 ml of complete DMEM with against V n /V 0 , and the dilution that reduced V n to 10% of V 0 (V n /V 0 Å 0.1) was scored as the neutralizing titer, as 15 mg per milliliter DEAE-Dextran. Some infections were also performed in the presence of 5 mM AZT (Sigma, St.
described by Nara et al. (1987) . As a negative control, prebleed plasma from all three animals was tested Louis, MO). Two hours after infection, an additional 1.5 ml of complete DMEM was added to each well. Three days against each virus. Scoring of blue nuclei in a 96-well format was greatly enhanced using an eyepiece reticule later, the medium was removed and cells were fixed with 1-2 ml of 1% formaldehyde-0.2% glutaraldehyde in phos-(10 1 10 grid) and a planar lens (Zeiss 2.51) to visualize the entire well. phate-buffered saline (PBS) for 5 min. Cells were then washed twice with PBS and stained with 600 ml of 4 mM
The levels of antibody specific for SIV gp160 were determined by ELISA, as described previously (Haigpotassium ferrocyanide, 4 mM potassium ferricyanide, 1 mM magnesium chloride, 0.4 mg per milliliter 5-bromo- 4-wood et al., 1992b; Planelles et al., 1991) , with the following modification: recombinant SIVMneCL8 envelope chloro-3-indolyl-b-D-galactopyranoside (X-gal) in PBS for 50 min at 37Њ in a non-CO 2 incubator. The staining was gp160 was purified from vaccinia virus-infected cells infected with Vac-160 (Hu et al., 1995) . stopped by removing the staining solution and washing thoroughly at least two times with PBS.
The infectious titer of some viral supernatants was RESULTS also determined by endpoint dilution of virus in CEM 1
Identification of sMAGI cell lines 174 cells. CEM 1 174 cells were infected with serial threefold dilutions of virus in triplicate. Productive virus
We engineered the CMMT adherent rhesus macaque infection was detected by assaying for SIV p27
gag antigen mammary tumor cell line to express human CD4 and an 2 weeks after infection by Enzyme Immunoassay as de-HIV-1 LTR-b-gal fusion. We examined the susceptibility scribed by the manufacturer (Coulter, Hialeah, FL). A tisto SIV infection of randomly chosen G418 (linked to CD4) sue culture infectious dose (TCID) was defined as the and hygromycin-B (linked to LTR-b-gal) resistant clones maximum dilution of virus where one of the CEM 1 174 by scoring blue nuclei in cells infected with SIVMneCL8. cultures became infected.
To exclude clones with a high background of cells expressing detectable b-gal activity, we also examined unNeutralization assays infected cells for blue nuclei. Of the 30 CMMT-CD4-LTRb-gal clones that we analyzed, 2 (clones 19 and 21) had Plasma samples were obtained from two M. nemesreproducibly high numbers of blue nuclei after infection trina (animals 93100 and 92263) infected with SIVMne, with SIVMneCL8 ( Fig. 1A) and a low number of blue an uncloned mixture from which SIVMneCL8 was derived nuclei after mock-infection (Fig. 1B) . We used clone 21 (Benveniste et al., 1986) , and a Macaca mulatta (animal for subsequent experiments because there was a slightly 176) infected with SIVsmE660 (Hirsch and Johnson, 1994) lower number of background blue nuclei in uninfected (grown in macaque PBMCs). Plasma samples were obcells. Based on the similarities between these cells and tained both prior to infection (prebleed) and 6 to 8 months the MAGI cells described by Kimpton and Emerman postinoculation. All plasma samples were heat-inacti-(1992), we renamed the CMMT-CD4-LTR-b-gal (clone 21) vated for 30 min at 56Њ. sMAGI cells were added to a 96-cells the simian MAGI (sMAGI) cell line. well plate 24 hr prior to infection at a density of 3.5 1 10 3 cells per well. The following day, plasma was serially Sensitivity of the sMAGI cells to SIV infection diluted twofold in complete DMEM to a final volume of 25 ml and added to an equal volume of virus. Typically,
We tested the sensitivity of the sMAGI cells to SIV infection by comparing the infectious titer of SIVMneCL8 virus stocks were diluted in complete DMEM to 100-200 infectious particles per 25 ml. The virus/plasma mixby sMAGI assay versus limiting dilution in CEM 1 174 cells, a cell line highly susceptible to SIV infection. ture was incubated at 37Њ in a 5% CO 2 incubator. After 45 min, medium was removed from the sMAGI cells, and sMAGI cells were infected with seven dilutions of virus in duplicate. At 3 days, cells were stained and a sMAGI then the sMAGI cells were infected with the virus/plasma mixture. At the time of infection, DEAE-Dextran was infectious dose was determined by counting the number of blue infectious centers. Clusters of blue nuclei found added to the virus/plasma mixture at a final concentration of 15 mg per milliliter. After 2 hr of infection, an additional in syncytia or dense clusters of blue nucleated cells, which probably result from the replication of infected 200 ml of complete DMEM was added. Three days after infection, medium was removed and the cells were fixed cells, were scored only once. Typically, infections of sMAGI cells with viral dilutions that result in 50 to 1000 and stained as described above. Neutralization was scored by comparing the average number of blue infecblue cells can be counted accurately in 12-well plates and are in the linear range of the assay (data not shown). tious centers in two wells in the presence of test plasma (V n ) with the number of infectious centers in the absence
In 12-well plates, an average of 5 blue nuclei, based on 25 experiments, were observed in uninfected controls of plasma (V 0 ). In each experiment, replicas of eight were used to determine the average V 0 . Dilutions were plotted (data not shown). The sMAGI infectious titer of this stock of SIVMneCL8 was 5 1 10 4 per milliliter. The TCID of SIV isolates differ in tropism and replication rate in different cell lines. To assess the infectivity of the sMAGI this virus stock was determined in parallel in CEM 1 174 cells and was also 5 1 10 4 per milliliter (Table 1A) . cell line, we tested six CEM 1 174-derived virus stocks, the original inoculum infect cell lines during the first 12 hr of infection (Kim et al., 1989; Pellegrino et al., 1991) . et al., 1991a,b) later. The number of blue nuclei were counted in infecand M87004 170wk (Rudensey et al., 1995) ]-and macrotions treated with AZT at 24 and 48 hr and in the untreated phage-tropic [SIVmac1A11 (Banapour et al., 1991a,b) and culture. In Fig. 2 these data are normalized by dividing SIVMneCL8 (Rudensey et al., 1995) ] SIV isolates. We the number of blue nucleated (infected) cells scored in compared the sMAGI infectivity titer of the six CEM 1 each case by the number of blue cells scored in wells 174-derived virus stocks with the TCID obtained by limin which infected cells were treated with AZT 24 hr after iting dilution infection of the CEM 1 174 cell line. These infection. Infection with SIVmac239 resulted in a steady results are summarized in Table 1A . The sMAGI infecincrease in the number of blue cells; there were approxitious dose was always the same or higher (up to eightmately 1.5 times more blue nucleated cells after 2 days fold) than the TCID in CEM 1 174 cells. We consistently of infection (treatment with AZT at 48 hr) and 2.5 times observed an eightfold difference between assays with more blue nucleated cells after 3 days of infection (no SIVmac239.
AZT) (Fig. 2) , indicating that SIVmac239 spread in the In order to determine whether viruses expressed in different cells are equally infectious for sMAGI cells, the infectious titer of stocks of the T-cell-tropic M87004 170wk SIVMneCL8 variant mixture grown in either C8166 cells or macaque PBMCs was determined using the sMAGI assay and CEM 1 174 endpoint dilution (Table  1B) . These stocks (as well as the M87004 170wk pool grown in CEM 1 174 cells) contain very similar populations of virus (Rudensey et al., 1993) . We also tested the macrophage-tropic clone SIVmac1A11 grown in macaque PBMCs. Again, the sMAGI assay shows similar sensitivity in comparison with the endpoint dilution method for each of these virus isolates; sMAGI infectious titers were equal to or up to fourfold greater than the TCID in CEM 1 174 cells. particles during a 3-day infection. The possibility exists at a low level (1:8 and 1:14) and both neutralized SIVmac239 at a low but detectable level (1:4). Plasma from the SIVsmE660-infected macaque neutralized SIVsmE660 at a titer of 1:140, but failed to show any neutralizing activity against SIVMne or SIVmac239. Prebleed plasma from all three animals failed to neutralize any of the SIV isolates tested (titer of õ1:4), demonstrating that neutralizing antibodies are specific to SIV. All three of the animals tested had no clinical signs of AIDS at the time of testing and the pattern of antibody production represented typical humoral immune responses (data not shown).
HIV-1 and HIV-2 infection of sMAGI cells CD4 (sMAGI) cells compared to the human HeLa-CD4 (MAGI) cells (Kimpton and Emerman, 1992) , CEM 1 174 sMAGI cells during the 3-day assay period. Thus, the cells, or human PBMCs (Table 3 ). The sMAGI cells were infectious titer of SIVmac239 may be slightly inflated not sensitive to infection by either of the laboratorywhen using the sMAGI assay. If this inflation was taken adapted HIV-1 strains that we tested, HIV-1 BAL (grown into account, sMAGI infectious titers of SIVmac239 were in CEM 1 174 cells) and HIV-1 LAI (grown in both CEM about 3 times higher than the TCID on CEM 1 174 cells, 1 174 cells and human PBMCs), nor were they susceptiwhich is in the range (i.e., 1-to 4-fold) of the other isolates ble to infection by several primary isolates of HIV-1. Cells that we tested. Thus, accurate sMAGI infectious titers of were infected with 5 to 100 ml of two uncharacterized SIVmac239 may be obtained by treating infected sMAGI mixtures of virus isolated from HIV-1-seropositive Kenyan cells with AZT 24 hr after infection. SIVMneCL8 and the individuals (MM1-2201 and BB2-2847) and one uncharac-M87004 170wk pool spread slowly in the sMAGI cell line, terized mixture isolated from an HIV-1-seropositive Ameras indicated by the fact that the number of infected cells ican (WH91-330). We observed background numbers of stayed fairly constant whether AZT was added at 24 hr blue nuclei when we infected with any of these virus or not (Fig. 2) . Thus, viral spread did not dramatically populations, even if the sMAGI cells were passaged for influence our calculations of the sMAGI infectious titer a week after infection before staining. of these virus isolates.
In contrast, the sMAGI cell line was susceptible to HIV-2 infection, although the infectivity varied among the Neutralization assay using sMAGI cells strains that we tested (Table 3B ). The infectivity titers of HIV-2 strains KR and CBL-20 were approximately 100-We were interested in determining the extent of neufold lower by the sMAGI assay compared to the MAGI tralizing activity of plasma from macaques infected with assay or endpoint dilution on human PBMCs. However, different strains of SIV against homologous and heterolosMAGI cells were relatively more sensitive to infection gous virus. Plasma from two M. nemestrina infected with by HIV-2 strains EHO, ROD, and D194; infectivity titers uncloned SIVMne or a M. mulatta infected with SIVwere about 5-to 10-fold less by the sMAGI assay comsmE660 was tested for virus neutralization activity pared to the MAGI assay or endpoint dilution on human against SIVMne, SIVsmE660, and SIVmac239 (all grown PBMCs. The infectivity for the sMAGI cells correlates on CEM 1 174 cells) using the sMAGI assay. Plasma with their relative ability to infect macaque PBMCs, and was tested in duplicate, using twofold dilutions from 1:4 both HIV-2 EHO and HIV-2 ROD have been shown to to 1:8192. Figure 3 demonstrates the range of the assay persistently infect rhesus macaques (Livartowski et al., for neutralization of SIVMne. SIVMne was strongly neu-1992). tralized by plasma from both of the macaques infected with SIVMne, at titers of 1:200 and 1:80, but not neutral-DISCUSSION ized by plasma from the SIVsmE660-infected macaque (titer of õ1:4). Plasma neutralization of all three virus
We have developed a rhesus macaque cell line that has broad sensitivity to infection by numerous SIV isostrains is shown in Table 2 . While neutralization of SIVMne was the highest in the SIVMne-infected macaques, lates as well as some sensitivity to HIV-2 infection and is useful in detecting infectious virus after a single cycle both sets of plasma also cross-neutralized SIVsmE660 of viral replication. The CMMT line was initially chosen ters with some viruses may be circumvented by the addibecause previous reports indicated that a CMMT-CD4 tion of AZT to sMAGI cells 24 hr after infection. Thus, for line is permissive for SIV infection (Goldstein et al., 1995;  all the SIV isolates that we tested, the determination of Hirsch et al., 1994) . The sMAGI cells are sensitive to infectious titer by the sMAGI assay is a highly sensitive infection by all the SIV strains that we tested, including and reproducible alternative to endpoint dilution in CEM (1) virus propagated in CEM 1 174 cells, C8166 cells, 1 174 cells. and macaque PBMCs, (2) molecular clones and un-A key advantage of the sMAGI cells is that detection of cloned mixtures, (3) cell-line-adapted and primary isovirus requires only one round of viral replication. Because lates, and (4) T-cell-and macrophage-tropic isolates.
these cells allow us to directly compare a broad specsMAGI infectious titers were consistently one-to eighttrum of viral isolates that have different replication rates, fold higher than the TCID defined by endpoint dilution in the sMAGI assay is ideally suited to determine neutraliz-CEM 1 174 cells. In the case of the virus (SIVmac239) ing titers against different SIV isolates. Neutralization which yields an eightfold higher sMAGI infectious titer, assays described to date (reviewed by D'Souza et al., a portion of this difference could be attributed to virus 1993) have utilized human cell lines or hybrid cell lines, spread in the sMAGI cells over the 3-day incubation pesuch as CEM 1 174, and readouts that are indirect, such riod. The tendency for moderately inflated infectious tias antigen production (Haigwood et al., 1992a; Planelles et al., 1991) or cytopathic effects (Montefiori et al., 1988) . Another widely applied assay that measures the inhibi- Clearly, the sMAGI neutralization assay is adaptable HIV-2 CBL-20 5 1 10 neutralization (Nara et al., 1987 short, and the assay yields statistically significant results.
